Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Sep 11, 2026
Purchase
Shares
6,000
Price
$1.88
Total Value
$11.25K
Shares Held After
17,324
% of Holdings
34.6%

TENAX THERAPEUTICS, INC. (TENX)

STAAB THOMAS R II — Chief Financial Officer
Sep 11, 2026
Purchase
Shares
5,675
Price
$1.94
Total Value
$10.98K
Shares Held After
15,675
% of Holdings
36.2%
Sep 11, 2026
Sale
Shares
1,274
Price
$153.06
Total Value
$195.00K
Shares Held After
175,245
% of Holdings
0.7%
Sep 11, 2026
Sale
Shares
4,577
Price
$151.72
Total Value
$694.40K
Shares Held After
176,519
% of Holdings
2.5%
Sep 11, 2026
Sale
Shares
6,520
Price
$150.62
Total Value
$982.04K
Shares Held After
181,096
% of Holdings
3.5%
Sep 11, 2026
Purchase
Shares
5,556
Price
$3.60
Total Value
$20.00K
Shares Held After
19,261
% of Holdings
28.8%
Sep 11, 2026
Sale
Shares
75,364
Price
$3.40
Total Value
$256.46K
Shares Held After
598,489
% of Holdings
11.2%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Sep 11, 2026
Sale
Shares
200
Price
$94.02
Total Value
$18.80K
Shares Held After
15,312
% of Holdings
1.3%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Sep 11, 2026
Sale
Shares
2,208
Price
$93.26
Total Value
$205.92K
Shares Held After
15,512
% of Holdings
12.5%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Sep 11, 2026
Sale
Shares
4,051
Price
$92.41
Total Value
$374.37K
Shares Held After
17,720
% of Holdings
18.6%

Oruka Therapeutics, Inc. (ORKA)

Agarwal Arjun — Senior Vice President, Finance
Sep 11, 2026
Sale
Shares
3,000
Price
$91.11
Total Value
$273.32K
Shares Held After
21,771
% of Holdings
12.1%
Sep 11, 2026
Sale
Shares
500
Price
$111.78
Total Value
$55.89K
Shares Held After
8,500
% of Holdings
5.6%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
3,270
Price
$205.81
Total Value
$672.99K
Shares Held After
291,876
% of Holdings
1.1%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
4,995
Price
$204.84
Total Value
$1.02M
Shares Held After
295,146
% of Holdings
1.7%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
17,949
Price
$203.87
Total Value
$3.66M
Shares Held After
300,141
% of Holdings
5.6%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
18,869
Price
$203.06
Total Value
$3.83M
Shares Held After
318,090
% of Holdings
5.6%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
21,447
Price
$201.75
Total Value
$4.33M
Shares Held After
336,959
% of Holdings
6.0%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
13,368
Price
$200.78
Total Value
$2.68M
Shares Held After
358,406
% of Holdings
3.6%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
11,833
Price
$200.11
Total Value
$2.37M
Shares Held After
371,774
% of Holdings
3.1%

Revolution Medicines, Inc. (RVMD)

Kelsey Stephen Michael — Senior Advisor to the Chief Executive Officer
Sep 11, 2026
Sale
Shares
800
Price
$198.55
Total Value
$158.84K
Shares Held After
383,607
% of Holdings
0.2%
Sep 11, 2026
Sale
Shares
32,802
Price
$0.32
Total Value
$10.50K
Shares Held After
0
% of Holdings
100.0%
Sep 11, 2026
Sale
Shares
1,750
Price
$13.99
Total Value
$24.48K
Shares Held After
139,252
% of Holdings
1.2%
Sep 11, 2026
Sale
Shares
8,450
Price
$13.99
Total Value
$118.22K
Shares Held After
672,498
% of Holdings
1.2%

Liquidia Corp (LQDA)

SINGH RAMAN — Director
Sep 11, 2026
Sale
Shares
9,024
Price
$68.62
Total Value
$619.21K
Shares Held After
44,637
% of Holdings
16.8%

Immunome Inc. (IMNM)

Higgins Jack — Chief Scientific Officer
Sep 11, 2026
Sale
Shares
13,200
Price
$25.32
Total Value
$334.22K
Shares Held After
65,050
% of Holdings
16.9%
Sep 11, 2026
Sale
Shares
27,136
Price
$70.11
Total Value
$1.90M
Shares Held After
0
% of Holdings
100.0%

Pharvaris N.V. (PHVS)

Lu Peng — President
Sep 11, 2026
Sale
Shares
15,000
Price
$40.13
Total Value
$601.95K
Shares Held After
65,179
% of Holdings
18.7%
Sep 11, 2026
Sale
Shares
280
Price
$508.21
Total Value
$142.30K
Shares Held After
324,443
% of Holdings
0.1%
Sep 11, 2026
Sale
Shares
320
Price
$507.31
Total Value
$162.34K
Shares Held After
324,723
% of Holdings
0.1%
Sep 11, 2026
Sale
Shares
518
Price
$506.44
Total Value
$262.34K
Shares Held After
325,043
% of Holdings
0.2%
Sep 11, 2026
Sale
Shares
82
Price
$504.97
Total Value
$41.41K
Shares Held After
325,561
% of Holdings
0.0%
Sep 11, 2026
Sale
Shares
710
Price
$503.99
Total Value
$357.83K
Shares Held After
325,643
% of Holdings
0.2%
Sep 11, 2026
Sale
Shares
850
Price
$503.10
Total Value
$427.63K
Shares Held After
326,353
% of Holdings
0.3%
Sep 11, 2026
Sale
Shares
1,560
Price
$502.13
Total Value
$783.32K
Shares Held After
327,203
% of Holdings
0.5%
Sep 11, 2026
Sale
Shares
476
Price
$500.86
Total Value
$238.41K
Shares Held After
328,763
% of Holdings
0.1%
Sep 11, 2026
Sale
Shares
204
Price
$499.61
Total Value
$101.92K
Shares Held After
329,239
% of Holdings
0.1%
Sep 11, 2026
Sale
Shares
1,021
Price
$498.97
Total Value
$509.45K
Shares Held After
329,443
% of Holdings
0.3%
Sep 11, 2026
Sale
Shares
2,138
Price
$497.99
Total Value
$1.06M
Shares Held After
330,464
% of Holdings
0.6%
Sep 11, 2026
Sale
Shares
1,341
Price
$496.74
Total Value
$666.13K
Shares Held After
332,602
% of Holdings
0.4%

BioNTech SE (BNTX)

Sahin Ugur — Chief Executive Officer
Sep 11, 2026
Sale
Shares
45,000
Price
$96.93
Total Value
$4.36M
Shares Held After
643,209
% of Holdings
6.5%
Sep 11, 2026
Purchase
Shares
1,493
Price
$65.94
Total Value
$98.46K
Shares Held After
540,000
% of Holdings
0.3%

Korro Bio, Inc. (KRRO)

Dolan Oliver — Senior Vice President, Finance
Sep 11, 2026
Sale
Shares
5
Price
$13.72
Total Value
$68.58
Shares Held After
16,241
% of Holdings
0.0%
Sep 11, 2026
Purchase
Shares
50,000
Price
$2.16
Total Value
$108.14K
Shares Held After
4,600,873
% of Holdings
1.1%
Sep 11, 2026
Purchase
Shares
50,000
Price
$2.16
Total Value
$108.14K
Shares Held After
4,311,828
% of Holdings
1.2%
Sep 11, 2026
Purchase
Shares
37,000
Price
$3.67
Total Value
$135.62K
Shares Held After
3,133,000
% of Holdings
1.2%
Sep 11, 2026
Sale
Shares
4,508
Price
$107.55
Total Value
$484.83K
Shares Held After
767,780
% of Holdings
0.6%
Sep 11, 2026
Sale
Shares
15,492
Price
$107.15
Total Value
$1.66M
Shares Held After
772,288
% of Holdings
2.0%

Aardvark Therapeutics, Inc. (AARD)

Sun Nelson — Chief Financial&Operating Officer
Sep 11, 2026
Sale
Shares
62,000
Price
$5.18
Total Value
$321.18K
Shares Held After
35,475
% of Holdings
63.6%
Sep 11, 2026
Sale
Shares
1,000
Price
$74.66
Total Value
$74.66K
Shares Held After
9,184
% of Holdings
9.8%
Sep 11, 2026
Sale
Shares
59,379
Price
$10.46
Total Value
$620.89K
Shares Held After
113,321
% of Holdings
34.4%
Version: v26.7.3